Altana Pharma/Nycomed Investigational Site

Philadelphia, Pennsylvania 19140

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124) — Completed
• Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125) — Completed